“Risk-Benefit Analysis of MRNA COVID-19 Vaccines for Omicron Variant Considering Age, Sex, and Comorbidity in Quality-Adjusted Life Years”

https://pubmed.ncbi.nlm.nih.gov/38115177

This study responds to letters regarding the risk-benefit analysis of mRNA COVID-19 vaccines for the Omicron variant, considering age, sex, and comorbidity in terms of quality-adjusted life years.